Anthropometric characteristics of X-linked hypophosphatemia
- PMID: 15057978
- DOI: 10.1002/ajmg.a.20572
Anthropometric characteristics of X-linked hypophosphatemia
Abstract
An anthropometric study was undertaken to assess head proportions of patients with X-linked hypophosphatemia (XLH). Fourteen morphometric parameters of the head were measured and 10 cephalic indices calculated in 82 affected persons (57 females and 25 males) from 55 unrelated families with XLH, and compared with the results obtained in the group of their healthy relatives (37 females and 33 males), as well as with general population control values. Normalized values (SD, z-score) were analyzed statistically. The group of healthy relatives, both males and females, differed significantly from Polish population control values in most of the normalized variables measured, making population control values useless as a control group for the analyzed XLH group. Intrafamilial values of cephalic parameters in healthy relatives of the XLH patients were finally applied for statistical analysis. Generally patients with XLH showed highly statistically significant increase in head length (males 0.95 +/- 1.07 vs. -0.37 +/- 1.02, females 0.57 +/- 1.59 vs. -0.06 +/- 1.15), significant decrease in occipital breadth (males -0.56 +/- 1.27 vs. 0.70 +/- 1.28, females -0.59 +/- 1.7 vs. 0.13 +/- 1.1) and several milder anomalies of craniofacial proportions. Mean cephalic index was significantly lower in XLH patients when compared with the healthy relatives (males -0.909 vs. 0.278 P < 0.0001, females -0.705 vs. 0.381 P = 0.007). The cephalic changes were found both in XLH children and XLH adults and were more pronounced in affected males than in females. There were no differences between offspring born by hypophosphatemic and normophosphatemic mothers.
Copyright 2003 Wiley-Liss, Inc.
Similar articles
-
X-linked hypophosphatemia: the mutant gene is expressed in teeth as well as in kidney.Am J Hum Genet. 1990 Mar;46(3):434-42. Am J Hum Genet. 1990. PMID: 2155529 Free PMC article.
-
High iFGF23 level despite hypophosphatemia is one of the clinical indicators to make diagnosis of XLH.Endocr J. 2011;58(8):647-55. doi: 10.1507/endocrj.k10e-257. Epub 2011 May 19. Endocr J. 2011. PMID: 21597229
-
Effect of GH replacement therapy in two male siblings with combined X-linked hypophosphatemia and partial GH deficiency.Eur J Endocrinol. 2003 Oct;149(4):317-21. doi: 10.1530/eje.0.1490317. Eur J Endocrinol. 2003. PMID: 14514346
-
X-linked hypophosphatemia: Management and treatment prospects.Joint Bone Spine. 2019 Nov;86(6):731-738. doi: 10.1016/j.jbspin.2019.01.012. Epub 2019 Jan 31. Joint Bone Spine. 2019. PMID: 30711691 Review.
-
Diagnosis, treatment-monitoring and follow-up of children and adolescents with X-linked hypophosphatemia (XLH).Metabolism. 2020 Feb;103S:153892. doi: 10.1016/j.metabol.2019.03.009. Epub 2019 Mar 27. Metabolism. 2020. PMID: 30928313 Review.
Cited by
-
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.Nat Rev Nephrol. 2019 Jul;15(7):435-455. doi: 10.1038/s41581-019-0152-5. Nat Rev Nephrol. 2019. PMID: 31068690 Free PMC article.
-
Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium.Front Endocrinol (Lausanne). 2021 Mar 19;12:641543. doi: 10.3389/fendo.2021.641543. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33815294 Free PMC article. Review.
-
Growth in X-linked hypophosphatemic rickets.Eur J Pediatr. 2007 Apr;166(4):303-9. doi: 10.1007/s00431-006-0357-z. Epub 2006 Dec 14. Eur J Pediatr. 2007. PMID: 17171343
-
Sex differences of burosumab in children with X-linked hypophosphataemic rickets.Pediatr Nephrol. 2023 Sep;38(9):3183-3187. doi: 10.1007/s00467-022-05822-9. Epub 2022 Dec 21. Pediatr Nephrol. 2023. PMID: 36542147
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources